Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid Tumors
Clinical trial NCT04630522 · COMPLETED
Trial details
- NCT number
- NCT04630522
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-31
- Primary completion
- 2023-03-31
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.